Hirotaka Miyashita

11PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer geneticsPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 25, 2026
GITR and GITR-L RNA Expression Levels Correlate with Better Survival and Response to Immunotherapy.

|May 05, 2026
GITR and GITR-L RNA Expression Levels Correlate with Better Survival and Response to Immunotherapy.

|Jan 08, 2026
Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) N-of-1 Precision Oncology Study: Molecular Profiling to Match Individually Dosed, Personalized Drug Combinations.

Jason K Sicklick, Daisuke Nishizaki, Hirotaka Miyashita

|Aug 24, 2023
Cancer-Immunity Marker RNA Expression Levels across Gynecologic Cancers: Implications for Immunotherapy.

Jessica Jou, Shumei Kato, Hirotaka Miyashita

|Aug 08, 2023
T-cell priming transcriptomic markers: implications of immunome heterogeneity for precision immunotherapy.

Hirotaka Miyashita, Razelle Kurzrock, Nicholas J Bevins

|Aug 15, 2021
Bone-modifying agents for bone loss in patients with prostate cancer receiving androgen deprivation therapy; insights from a network meta-analysis.

Hirotaka Miyashita, Sera Satoi, Christina Cruz

Pageof 2

Frequent Collaborators

5 joint publications

Razelle Kurzrock

4 joint publications

Shumei Kato

3 joint publications

Jason K Sicklick

3 joint publications

Mina Nikanjam